Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAX |
| Upstream (Parents) |
|---|
| (<<) NCRNA00271///GAPDHL19 → MAX |
| (<<) NBR2 → MAX |
| (<<) MYST3 → MAX |
| (<<) LOC100287590 → MAX |
| (<<) ATPAF2 → MAX |
| (<<) SH3D19///RUNX1 → MAX |
| (<<) FPR3 → MAX |
| (<<) PROL1 → MAX |
| (<<) NFYA → MAX |
| Downstream (Children) |
|---|
| MAX → MED18 (>>) |
| MAX → NCRNA00271///GAPDHL19 (>>) |
| MAX → EXTL1 (>>) |
| MAX → C17orf59 (>>) |
| MAX → LOC100287590 (>>) |
| MAX → GLP2R (>>) |
| MAX → ATPAF2 (>>) |
| MAX → SH3D19///RUNX1 (>>) |
